

House
File
2141
-
Introduced


HOUSE
FILE
2141


BY
SHIPLEY


A
BILL
FOR


An
Act
relating
to
information
to
be
provided
by
the
department
1


of
public
health
regarding
vaccines
and
information
2


distributed
through
the
Iowa
immunization
program.
3


BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
4


TLSB
5774YH
(3)
88


pf/rh



H.F.
2141


Section
1.
IOWA
IMMUNIZATION
PROGRAM
——
INFORMATION
1


REQUIRED.
The
department
of
public
health
shall
require
2


that
vaccines
and
information
distributed
through
the
Iowa
3


immunization
program
include
a
copy
of
42
U.S.C.
§300aa-22,
4


and
a
statement
explaining
the
law
in
plain
language,
5


regarding
the
limitation
of
liability
of
a
manufacturer
of
a
6


vaccine,
including
the
excipients
added
to
the
vaccine,
for
7


a
vaccine-related
injury
or
death
resulting
from
unavoidable
8


adverse
side
effects
or
failure
to
provide
direct
warning
of
9


potential
dangers.
The
vaccines
and
information
distributed
10


shall
also
include
the
centers
for
disease
control
and
11


prevention
of
the
United
States
department
of
health
and
human
12


services
vaccine
excipient
summary
for
the
specific
vaccine
13


type
and,
unless
information
is
available
to
the
contrary,
a
14


statement
that
the
adjuvants
in
the
vaccine
have
inherent,
15


unavoidable
risks
and
have
not
been
scientifically
evaluated
16


for
long-term
adverse
events
or
against
the
adjuvants
of
any
17


other
vaccine.
18


EXPLANATION
19


The
inclusion
of
this
explanation
does
not
constitute
agreement
with
20


the
explanation’s
substance
by
the
members
of
the
general
assembly.
21


This
bill
relates
to
the
Iowa
immunization
program
under
the
22


purview
of
the
department
of
public
health
(DPH)
that
includes
23


the
activities
funded
by
the
federal
vaccines
for
children
24


program.
25


The
bill
requires
DPH
to
require
that
vaccines
and
26


information
distributed
through
the
Iowa
immunization
27


program
include
certain
information.
The
information
28


required
includes:
a
copy
of
the
federal
law,
42
U.S.C.
29


§300aa-22,
relating
to
the
standards
of
responsibility
for
30


manufacturers
of
vaccines
that
provide
that
a
manufacturer
31


is
immune
from
liability
in
a
civil
action
for
damages
32


arising
from
a
vaccine-related
injury
or
death
associated
33


with
the
administration
of
a
vaccine
after
October
1,
1988,


34


if
the
injury
or
death
resulted
from
side
effects
that
were
35


-1-


LSB
5774YH
(3)
88


pf/rh


1/
2



H.F.
2141


unavoidable
even
though
the
vaccine
was
properly
prepared
1


and
was
accompanied
by
proper
directions
and
warnings,
or
2


solely
due
to
the
manufacturer’s
failure
to
provide
direct
3


warnings
to
the
injured
party
(or
the
injured
party’s
legal
4


representative)
of
the
potential
dangers
resulting
from
the
5


administration
of
the
vaccine
manufactured
by
the
manufacturer;
6


a
statement
explaining
the
law
in
plain
language
regarding
7


the
limitation
of
liability
of
a
manufacturer
of
a
vaccine,
8


including
the
excipients
added
to
the
vaccine;
the
centers
9


for
disease
control
and
prevention
of
the
United
States
10


department
of
health
and
human
services
vaccine
excipient
11


summary
for
the
specific
vaccine
type
and,
unless
information
12


is
available
to
the
contrary,
a
statement
that
the
adjuvants
13


in
the
vaccine
have
inherent,
unavoidable
risks
and
have
not
14


been
scientifically
evaluated
for
long-term
adverse
events
or
15


against
the
adjuvants
of
any
other
vaccine.
16


An
excipient
is
an
ingredient
contained
in
a
vaccine
in
17


addition
to
weakened
or
killed
disease
antigens.
An
adjuvant
18


is
an
excipient
that
is
added
to
the
vaccine
to
help
stimulate
19


a
stronger
immune
response
and
includes
aluminum
salts.
20


-2-


LSB
5774YH
(3)
88


pf/rh


2/
2

